Medicure Inc. Files 6-K, Announces Financial Results Presentation
Ticker: MCUJF · Form: 6-K · Filed: Apr 5, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financial-results, foreign-private-issuer
TL;DR
Medicure Inc. filed a 6-K, looks like they're about to drop financial results.
AI Summary
On April 4, 2024, Medicure Inc. filed a Form 6-K report with the SEC. The filing includes a news release announcing that the company will present its financial results. Dr. Albert D. Friesen, CEO, signed the report.
Why It Matters
This filing indicates Medicure Inc. is preparing to share its financial performance, which could influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial information or material events.
Key Players & Entities
- Medicure Inc. (company) — Registrant
- Dr. Albert D. Friesen (person) — CEO and signatory
- April 4, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2024, and includes Exhibit 99.1, a news release.
Who is the CEO of Medicure Inc. and what is their role in this filing?
Dr. Albert D. Friesen is the CEO of Medicure Inc. and signed the report on behalf of the registrant.
When was this Form 6-K filed?
The filing was made on April 5, 2024, and the report is as of April 4, 2024.
What is the primary business of Medicure Inc. according to the filing?
Medicure Inc. is classified under Standard Industrial Classification as 'Pharmaceutical Preparations [2834]'.
Does Medicure Inc. file annual reports under Form 20-F or Form 40-F?
Medicure Inc. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 145 words · 1 min read · ~1 pages · Grade level 8.3 · Accepted 2024-04-04 19:06:30
Filing Documents
- med_6k.htm (6-K) — 8KB
- med_ex991.htm (EX-99.1) — 13KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-24-004270.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: April 4, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3